OP Corporate Bank plc's Interim Report 1 January–31 March 2024 [Yahoo! Finance]
Nasdaq, Inc. (NDAQ)
Last nasdaq, inc. earnings: 4/22 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.nasdaq.com
Company Research
Source: Yahoo! Finance
OP Corporate Bank plc's Interim Report 1 January–31 March 2024 OP Corporate Bank plc's operating profit rose to EUR 112 million (81). Net interest income grew by 23% to EUR 157 million (127). Investment income fell by 72% to EUR 9 million (31). Net commissions and fees increased to EUR 19 million (17). Impairment loss on receivables totalled EUR 12 million (11). Total operating expenses decreased by 24% to EUR 71 million (94). The cost/income ratio improved to 36% (50). In the year to March, the loan portfolio grew by 2.0% to EUR 27.8 billion (27.3) and the deposit portfolio by 7.1% to EUR 13.3 billion (12.4). The Corporate Banking and Capital Markets segment's operating profit increased to EUR 80 million (33). Net interest income grew by 38% to EUR 97 million (70). Investment income fell by 45% to EUR 10 million (18). Operating expenses decreased by 32% to EUR 30 million (44). Impairment loss on receivables reversed amounted to EUR 1 million. A year ago, impairment loss
Show less
Read more
Impact Snapshot
Event Time:
NDAQ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NDAQ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NDAQ alerts
High impacting Nasdaq, Inc. news events
Weekly update
A roundup of the hottest topics
NDAQ
News
- Delisting of Securities of Better Therapeutics, Inc.; Tritium DCFC Limited; Arcimoto, Inc.; Next.e.GO N.V.; Acutus Medical, Inc.; and NeuBase Therapeutics, Inc. from The Nasdaq Stock MarketGlobeNewswire
- Nasdaq to Enhance Global Market Surveillance Offering with Generative AIGlobeNewswire
- Nasdaq Announces 2024 Annual Meeting of ShareholdersGlobeNewswire
- Nasdaq, Inc. (NASDAQ: NDAQ) had its price target raised by analysts at Argus from $64.00 to $66.00. They now have a "buy" rating on the stock.MarketBeat
- Nasdaq Weighs Sale of Solovis Amid Streamlining Effort [BNN Bloomberg (Canada)]BNN Bloomberg
NDAQ
Earnings
- 4/26/24 - Miss
NDAQ
Sec Filings
- 5/3/24 - Form 4
- 5/3/24 - Form 8-K
- 5/3/24 - Form 424B7
- NDAQ's page on the SEC website